MW187A1 - Benzazecine derivatives - Google Patents
Benzazecine derivativesInfo
- Publication number
- MW187A1 MW187A1 MW1/87A MW187A MW187A1 MW 187 A1 MW187 A1 MW 187A1 MW 1/87 A MW1/87 A MW 1/87A MW 187 A MW187 A MW 187A MW 187 A1 MW187 A1 MW 187A1
- Authority
- MW
- MALAWI
- Prior art keywords
- chloro
- cpds
- acetyl
- benzazecine
- methoxybenzoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D227/00—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
- C07D227/02—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D227/06—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D227/08—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Benzazecine cpds of the formula (I) and benzoquinoline cpds of the formula (II) are new. R1 and R2 are each independently H or Cl; R3 is H, F, Cl, Br or OCH3; R4 is H, Cl or OCH3, and two or three of R1, R2, R3 and R4 are H; R5 is H, acetyl, propionyl, benzoyl, chloro benzoyl, methoxybenzoyl or phenylacetyl Also in (I) R5 may be a cleavable gp (Z) other than the acyl. - Eighteen cpds (I) including 4-acetyl-9-chloro-1,2,4,5,6,7 - hexahydro-4-benzazecine-3,8-dione and the corresp 4-acetyl-9,11-dichloro, 4-propionyl-11-chloro, 4-(p-methoxybenzoyl) -11-chloro, 9-chloro, 11-chloro-4-phenylacetyl and 4-acetyl-11-bromo cpds are specifically claimed.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH26686 | 1986-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MW187A1 true MW187A1 (en) | 1987-10-14 |
Family
ID=4183090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MW1/87A MW187A1 (en) | 1986-01-23 | 1987-01-20 | Benzazecine derivatives |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US4732979A (en) |
| EP (1) | EP0230967B1 (en) |
| JP (1) | JPS62169770A (en) |
| KR (1) | KR910000659B1 (en) |
| CN (1) | CN1013111B (en) |
| AT (1) | ATE68790T1 (en) |
| AU (1) | AU590042B2 (en) |
| CS (1) | CS258147B2 (en) |
| DD (1) | DD264431A5 (en) |
| DE (1) | DE3773950D1 (en) |
| DK (1) | DK35887A (en) |
| FI (1) | FI82931C (en) |
| GB (1) | GB2185744B (en) |
| HU (1) | HU197883B (en) |
| IE (1) | IE870167L (en) |
| IL (1) | IL81317A (en) |
| IS (1) | IS3190A7 (en) |
| MC (1) | MC1795A1 (en) |
| MT (1) | MTP996B (en) |
| MW (1) | MW187A1 (en) |
| NO (1) | NO167385C (en) |
| NZ (1) | NZ218987A (en) |
| OA (1) | OA08469A (en) |
| PH (1) | PH22879A (en) |
| PL (1) | PL263796A1 (en) |
| PT (1) | PT84181B (en) |
| TN (1) | TNSN87006A1 (en) |
| YU (1) | YU7087A (en) |
| ZA (1) | ZA87407B (en) |
| ZW (1) | ZW1087A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS258147B2 (en) * | 1986-01-23 | 1988-07-15 | Hoffmann La Roche | Method of benzazecine's new derivatives production |
| IN167395B (en) * | 1987-07-21 | 1990-10-20 | Hoffmann La Roche | |
| US5250539A (en) * | 1991-08-21 | 1993-10-05 | Eli Lilly And Company | Hexahydrobenzo[f]quinolinones |
| US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
| EP0591582B1 (en) * | 1991-08-21 | 1999-01-20 | Eli Lilly And Company | Hexahydrobenzo (f) quinolinones as 5-alpha-reductase inhibitors |
| ES2169026T3 (en) * | 1991-08-21 | 2002-07-01 | Lilly Co Eli | BENZO (F) QUINOLINONES AS INHIBITORS OF 5-ALFA-REDUCTASA. |
| WO1994022444A1 (en) * | 1993-03-29 | 1994-10-13 | Smithkline Beecham Corporation | Tricyclic compounds for inhibiting platelet aggregation |
| GB9317314D0 (en) * | 1993-08-20 | 1993-10-06 | Smithkline Beecham Corp | Compounds |
| DE69515321T2 (en) | 1994-09-20 | 2000-08-24 | The Regents Of The University Of California, Oakland | BREFELDIN A AND ANALOGS TO IMPROVE SYNAPTIC TRANSMISSIONS |
| US20050067341A1 (en) * | 2003-09-25 | 2005-03-31 | Green Dennis H. | Continuous production membrane water treatment plant and method for operating same |
| US7094331B2 (en) * | 2003-11-05 | 2006-08-22 | Marathon Ashland Petroleum Llc | Viscosity modification of heavy hydrocarbons using dihydric alcohols |
| US20090263439A1 (en) * | 2008-04-18 | 2009-10-22 | The Procter & Gamble Company | Antimicrobial Preservative Free Wipe |
| CN106117028B (en) * | 2016-06-14 | 2019-01-01 | 浙江永太药业有限公司 | A kind of process preparing halogenated -3,4- dihydro -1H-2- naphthalenone |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE442586A (en) * | 1940-07-31 | |||
| JPS5129710B2 (en) * | 1972-09-09 | 1976-08-27 | ||
| US4341786A (en) * | 1981-03-02 | 1982-07-27 | Smithkline Corporation | Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds |
| US4521423A (en) * | 1983-10-31 | 1985-06-04 | Ayerst, Mckenna & Harrison, Ltd. | 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them |
| CS258147B2 (en) * | 1986-01-23 | 1988-07-15 | Hoffmann La Roche | Method of benzazecine's new derivatives production |
-
1987
- 1987-01-20 CS CS87418A patent/CS258147B2/en unknown
- 1987-01-20 IL IL81317A patent/IL81317A/en unknown
- 1987-01-20 YU YU00070/87A patent/YU7087A/en unknown
- 1987-01-20 AT AT87100733T patent/ATE68790T1/en not_active IP Right Cessation
- 1987-01-20 ZA ZA87407A patent/ZA87407B/en unknown
- 1987-01-20 FI FI870220A patent/FI82931C/en not_active IP Right Cessation
- 1987-01-20 DE DE8787100733T patent/DE3773950D1/en not_active Expired - Lifetime
- 1987-01-20 EP EP87100733A patent/EP0230967B1/en not_active Expired - Lifetime
- 1987-01-20 NZ NZ218987A patent/NZ218987A/en unknown
- 1987-01-20 MW MW1/87A patent/MW187A1/en unknown
- 1987-01-20 PH PH34744A patent/PH22879A/en unknown
- 1987-01-21 HU HU87163A patent/HU197883B/en not_active IP Right Cessation
- 1987-01-21 DD DD87299380A patent/DD264431A5/en unknown
- 1987-01-21 ZW ZW10/87A patent/ZW1087A1/en unknown
- 1987-01-21 US US07/005,712 patent/US4732979A/en not_active Expired - Fee Related
- 1987-01-22 IE IE870167A patent/IE870167L/en unknown
- 1987-01-22 IS IS3190A patent/IS3190A7/en unknown
- 1987-01-22 AU AU67911/87A patent/AU590042B2/en not_active Ceased
- 1987-01-22 CN CN87100312A patent/CN1013111B/en not_active Expired
- 1987-01-22 DK DK035887A patent/DK35887A/en not_active Application Discontinuation
- 1987-01-22 PT PT84181A patent/PT84181B/en not_active IP Right Cessation
- 1987-01-22 TN TNTNSN87006A patent/TNSN87006A1/en unknown
- 1987-01-22 JP JP62011477A patent/JPS62169770A/en active Pending
- 1987-01-22 MT MT996A patent/MTP996B/en unknown
- 1987-01-22 GB GB8701416A patent/GB2185744B/en not_active Expired
- 1987-01-22 MC MC871868A patent/MC1795A1/en unknown
- 1987-01-22 NO NO870280A patent/NO167385C/en unknown
- 1987-01-23 PL PL1987263796A patent/PL263796A1/en unknown
- 1987-01-23 KR KR1019870000533A patent/KR910000659B1/en not_active Expired
- 1987-01-23 OA OA59052A patent/OA08469A/en unknown
- 1987-11-18 US US07/121,987 patent/US4749791A/en not_active Expired - Fee Related
-
1988
- 1988-02-11 US US07/154,760 patent/US4876340A/en not_active Expired - Fee Related
-
1989
- 1989-08-17 US US07/395,380 patent/US4957911A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2185744B (en) | Benzazecine derivatives | |
| GB2126226B (en) | Pyridine derivatives | |
| LU90219I2 (en) | Tolcapone and its pharmaceutically acceptable derivatives (TASMAR) | |
| LU88790I2 (en) | Moxidectin and its pharmaceutically acceptable derivatives | |
| FI812635L (en) | PIPERIDYLIDENDERIVAT DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL BLANDNINGAR | |
| NZ218682A (en) | Monosulphactam derivatives | |
| MY102270A (en) | New furanuronic acid derivatives, process their production and their use. | |
| GR3005176T3 (en) | ||
| FI884345A0 (en) | SACKARIDDERIVAT. | |
| NO911798L (en) | 3'-DEAMINO-4'-DEOXY-4'-AMINO-8-FLUORANTRACYCLINES AND THEIR PREPARATION. | |
| KR900702028A (en) | In vitro synthesis of infectious RNA | |
| RO96381A2 (en) | PROCEDURE FOR SYNTHESIS OF AZOBISCICLOPENTANCARBONITRILE | |
| ES2059097T3 (en) | DERIVATIVES OF ERGOLINE. | |
| GR880100196A (en) | Substituted 1,3-dioxolane and 1,3-dioxane derivatives processes for the production and their use | |
| FI96606C (en) | Process for the preparation of novel therapeutically useful 2'-ethinylcytidine, uridine and guanocine derivatives |